期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 16, 页码 7285-7289出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm300564b
关键词
-
资金
- NIH/NCI [R01CA148706]
- GTx, Inc
Novel ABI-III compounds were designed and synthesized based on our previously reported ABI-I and ABI-II analogues. ABI-III compounds are highly potent against a panel of melanoma and prostate cancer cell lines, with the best compound having an average IC50 value of 3.8 nM. They are not substrate of Pgp and thus may effectively overcome Pgp-mediated multidrug resistance. ABI-III analogues maintain their mechanisms of action by inhibition of tubulin polymerization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据